Captor Therapeutics signs $2 million Michael J. Fox Foundation grant deal for NEK7 project
Captor Therapeutics SA has signed a $2 million grant agreement with the Michael J. Fox Foundation to fund advanced research and development for drug candidates targeting protein degradation while retaining full intellectual property rights for the project and technologies.
Sept 29 - Captor Therapeutics SA said it has signed a $2 million grant agreement with The Michael J. Fox Foundation for its Nek7 project. The grant is to fund advanced research and development for drug candidates targeting protein degradation, and the company said it will retain full intellectual property rights for the project and technologies. WA (Gdansk Newsroom) (+48 58 769 66 00).